New SPECT Study Unveils Significant Brain Activity Differences in Depression
Researchers in a groundbreaking neuroimaging study have discovered that individuals with depression exhibit significantly higher levels of blood flow in various brain regions. Key findings from the study indicate that depressed patients show increased blood flow in critical brain areas,…
COAST GUARD VETERAN WALKING ACROSS AMERICA TO RAISE AWARENESS FOR MENTAL HEALTH
The Coast Guard Foundation, a non-profit organization committed to strengthening the Coast Guard community and service by supporting members and families, announced that Robert Luna, a retired Coast Guard veteran and chief petty officer, is walking from Alabama to California to raise awareness for mental…
Manasthali gives a new lease of life to a young man affected by Schizophrenia
Manasthali, a renowned mental health organization dedicated to offering innovative and compassionate treatment, has revitalised the life of a 28-year-old schizophrenia patient by providing him with the right support and treatment for his mental health condition. Schizophrenia is a complicated…
Acharya Prashant Engages with IIT Students on Mental Health and Spiritual Well-being
Acharya Prashant, founder of PrashantAdvait Foundation and former civil service officer, interacted with IIT students on mental health. More than 1000 people from across the country participated in the session. He said that there is a deep connection between the…
Neurocrine Biosciences Announces First-Patient Dosed in Phase 2 Clinical Study Evaluating NBI-1070770 in Adults with Major Depressive Disorder
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the first patient has been randomized for its Phase 2 clinical study to evaluate the efficacy, safety, and tolerability of investigational compound NBI-1070770 in adults with major depressive disorder. NBI-1070770 is a novel,…
NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced clearance from the U.S. Food and Drug Administration (FDA) for NeuroStar…
Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s Technology
Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that it has commenced sales of its second generation (Gen-2), 15 milliamp (mA) neurostimulation device into a new mental health center in Oman, dedicated to the use of…
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Reports Comments by Strategic Partner Lotus Pharmaceutical Co. Ltd. (1975.TW) in Recent Financial Report
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced that its Asia Pacific strategic partner Lotus Pharmaceutical Co. Ltd (1975.TW) identified enrollment completion of the NRx clinical trial in bipolar depression as a material event in is February…
Family Care Center Expands Mental Health Support with New Nashville West End Clinic
Family Care Center, one of the nation’s premier mental health providers, is celebrating the opening of its newest clinic in Nashville’s West End neighborhood. This marks the company’s fourth outpatient mental health clinic in the Nashville area, with plans for continued growth in the…
Clinical trial on Ambio Life Sciences’ ibogaine treatment for Navy SEALs with traumatic brain injury published in Nature Medicine
Today, Nature Medicine published the results of a clinical trial, in which 30 former Navy SEALs were administered ibogaine at Ambio Life Sciences in Mexico to treat traumatic brain injuries, which they developed during their military careers. The results show incredible promise for ibogaine to treat…
